News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AnGes MG Inc. And Rush University To Conclude Licensing Agreement For NF-kappa B Decoy Oligodeoxynucleotide



10/19/2005 5:09:21 PM

Tokyo (JCNN) - AnGes MG (TSE: 4563) announced on June 21 that it has concluded a licensing agreement with Rush University concerning the development of NF-kappa B decoy oligodeoxynucleotide (NFkB decoy oligo), a kind of nucleic acid medicine developed by AnGes MG.

Read at JCN Newswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES